HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study.
Guillaume BretonOumou Hawa DialloMohamed CisséOumou Hawa DialloNéné Aissatou DialloSény Agnès SoumaoroYalikhatou CamaraAlice MontoyoChristine RouziouxYoussouf KoitaGilles PeytavinRoland TubianaPierre Frangenull nullPublished in: The Journal of antimicrobial chemotherapy (2022)
Reinforced antiretroviral prophylaxis and EID at birth are widely feasible. However, mothers' self-disclosure of HIV status and antiretroviral intake do not allow adequate evaluation of MTCT risk, which argues for maternal pVL measurement near delivery. Furthermore, actions against stigmatization are crucial to improve PMTCT.
Keyphrases
- hiv aids
- hiv infected
- hiv positive
- antiretroviral therapy
- human immunodeficiency virus
- men who have sex with men
- hiv infected patients
- hiv testing
- south africa
- hepatitis c virus
- randomized controlled trial
- systematic review
- mental health
- birth weight
- pregnancy outcomes
- gestational age
- physical activity
- mental illness
- depressive symptoms
- weight loss
- body mass index
- preterm birth